How to reduce risk: Document thoroughly (evaluation, informed consent, follow-ups) Coordinate with patients primary care providers Follow state-specific protocols religiously (especially FLs quarterly follow-ups, NJs counseling requirements) Use FDA-approved medications (avoid unregulated compounded semaglutide unless you understand the legal exposure) Set realistic patient expectations (no guaranteed results, lifestyle modification required) The Bottom Line: Should You Add Weight Management to Your Telehealth Practice
Menu News Needle Little Transparency: Alabama AG Targets Research-Grade GLP-1s Alabama AG Steve Marshall obtained a temporary restraining order against Aurora IV and Wellness, an infusion clinic, and its owners in a case alleging that they administered research-grade weight loss drugs without patients knowledge or consent, in violation of Alabamas Deceptive Trade Practices Act
epidemiologists and outcomes researchers need to track long-term effectiveness and safety
A woman who lost almost 100 pounds on the weight loss drug semaglutide said it prevented her from spending $30,000 on bariatric surgery
A: Contraindications include diabetes type 1, personal or family history of thyroid cancer (Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Syndrome type 2), hypersensitivity to drug, pregnancy- caution with renal impairment, GI disease, gastroparesis, pancreatitis and diabetic retinopathy